UniCredit to Take ‘Timely' Steps on BPM After Court Decision
UniCredit welcomed the decision as 'unequivocal proof that the way in which Golden Power was illegitimate,' the bank said in a statement Sunday, referring the process that allows authorities to block or impose conditions on transactions involving strategic assets. 'UniCredit will now evaluate all relevant steps in a timely manner,' it added.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
30 minutes ago
- Yahoo
Legendary & Lionsgate, Upstart, Best Buy: Trending Tickers
Here are some of the stocks that are trending on July 14. Legendary Entertainment is considering a bid for Lionsgate (LION), according to a report from Bloomberg. A Goldman Sachs analyst assumed coverage of Upstart Holdings (UPST), giving it a Sell rating. Shares of Best Buy (BBY) were downgraded to Neutral from Overweight at Piper Sandler. To watch more expert insights and analysis on the latest market action, check out more Market Catalysts here. Now here's a look at some of today's training tickers. We're watching Lionsgate, Upstart and Best Buy. First up, Lionsgate, that's the studio behind films like The Hunger Games, John Wick and Twilight, could be a potential takeover target. Bloomberg News reporting that legendary entertainment is considering a takeover of the studio. Legendary is an independent film and TV studio behind the Dune trilogy and the Minecraft movie. Um, our Brook Depalma is still with me. Lionsgate moving up a little bit today. This crossed sort of late in the session, almost at the end of the session on Friday. Um, but and it's interesting because Lionsgate had just separated from stars relatively recently, and now you see this kind of report out there. Absolutely. If you take a look year to date, Lionsgate is down more than 13%, but this momentum from Friday is certainly accelerating into today with shares uh shares down uh 6%. So what we really are trying to understand is what exactly this could look like. Also, with this new news out that Legendary is eyeing Lionsgate, other investors or other analysts on the street are saying that, could this propose other players to take a closer look at Lionsgate as well. Could uh this essentially lead to other bids like we've seen in the past? Once again to say, and point out this entity. Once again, as you noted, behind Dune, we know it's behind John Wick, even behind Hunger Games. And so there's some known names, and I feel like now that the attention has been brought to the possibility under Lionsgate that that understanding of what exactly this could look like and who exactly could win out this bid is a bit unsetting. We also know that uh Bloomberg Intelligence uh Intelligence analysts coming out saying that legendary's exploration of a Lionsgate takeover is sensible given that it's a pure play studio here, but perhaps investors really wanting more here. And and let's also talk about Upstart, Brook, the online lending platform falling today after Goldman Sachs initiated coverage of the company with a sell rating. Analyst William Nance saying he sees limited progress on driving long-term consumer relationships. His price target set at $71, the shares down about 3% here today, and it's not the only analyst who's negative on this company. Yeah, what we're seeing here is a stock that has really rallied over the course year to date up more than 19%. Some things that analysts are really pointing out here is this concern about the company's limited progress in developing long-term consumer relationships, also noting that the online personal loan market is competitive and indirect, and also there's this heavy reliance on cyclical third-party funding. And so what we're seeing here is once again that stock that has rallied year to date of 19%. We're seeing a bit of a pullback as investors understand or really look out to see how much more room that has to run. Shares down 4% over the past five days and down just 3% today alone. Yes. And then, uh, in your neck of the woods, Best Buy getting a downgrade over at Piper Sandler from overweight to neutral. The analyst there saying the company lacks any meaningful catalyst in the coming quarters. It's also facing competition concerns. Those shares down 3% also, Brook. Yeah, Best Buy has really been under pressure. If you take a closer look year to date, we've seen this company really struggle as President Trump's tariffs have gone into effect. Year to date, shares are down nearly 19%, and what we've heard from Best Buy CEO Cory uh Barry in the past is that they have to have consumers willing to spend on that new technology, like computers and tablets, that really may be have that new AI technology. Best Buy has really bet on that, banking on consumers really wanting and willing to splurge and spend. But as we've seen here, consumers are really looking where they can buy the best deal. Are they going other places, like a Walmart or an Amazon, especially over the course of this past month during those key deal weeks in order to get that savings? And ultimately, what exactly are they waiting for here? Are they really going to splurge and spend on that new AI technology like Best Buy has been banking on? Of course, it'll be interesting to see how that Nintendo Switch did over the past quarter as well and their upcoming report. Brook, thank you very much. And you can scan the QR code below to check the best and worst performing stocks with Yahoo Finances training tickers page. Sign in to access your portfolio
Yahoo
35 minutes ago
- Yahoo
China Blinks: Synopsys Just Won the $35B Tech Deal Everyone Thought Might Collapse
After months of geopolitical overhang, Synopsys (NASDAQ:SNPS) just cleared one of the last major roadblocks in its $35 billion acquisition of Ansys. China's top antitrust regulator gave the deal the green lightwith a catch. Synopsys must continue renewing contracts with existing customers, a condition likely designed to prevent future service disruptions in the Chinese market. While subtle, the move signals Beijing's willingness to separate business from politicsat least this timegiving Synopsys the go-ahead to finalize a transaction already approved by regulators in the U.S. and Europe. The deal's timing wasn't without drama. Earlier this year, Synopsys and Cadence were briefly swept into Washington's escalating tech cold war with Beijing, as U.S. officials mulled new export restrictions on advanced chip design software. The proposal was quickly pulled, but it rattled nerves on both sides of the Pacific. Investors had reason to worry: China's market is too big to ignore in the semiconductor world, and delays have tanked deals before. Qualcomm's $44 billion bid for NXP collapsed in 2018, and Intel's $5.4 billion offer for Tower Semiconductor was shelved just last yearboth due to Chinese regulatory silence. Now that approval is secured, Synopsys could be positioned to cement its dominance in the chip design software spacean area increasingly viewed as critical infrastructure in the global tech race. Investors took notice: SNPS rose as much as 3.7% in premarket trading and is now up roughly 15% year to date. With the Ansys deal nearly over the finish line, Synopsys may be gearing up for its next chapterone that blends engineering software and chip design tools in a way few others can match. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
37 minutes ago
- Yahoo
Eurofins: Purchases of Own Shares From July 7th to July 11th 2025
LUXEMBOURG, July 14, 2025--(BUSINESS WIRE)--Regulatory News: Eurofins (Paris:ERF): Name of the Issuer Identity code of the Issuer Day of the transaction Identity code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS 529900JEHFM47DYY3S57 07/07/2025 FR0014000MR3 10,000 60.4588 XPAR EUROFINS 529900JEHFM47DYY3S57 08/07/2025 FR0014000MR3 10,000 59.5725 XPAR EUROFINS 529900JEHFM47DYY3S57 09/07/2025 FR0014000MR3 20,000 59.8384 XPAR EUROFINS 529900JEHFM47DYY3S57 10/07/2025 FR0014000MR3 20,000 60.0554 XPAR EUROFINS 529900JEHFM47DYY3S57 11/07/2025 FR0014000MR3 10,000 60.5362 XPAR TOTAL 70,000 60.0507 Transaction details In accordance with Article 5(1)(b) of Regulation (EU) N° 596/2014 (the Market Abuse Regulation) a full breakdown of the individual trades are disclosed on Eurofins Scientific SE website: View source version on Contacts Eurofins Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
